BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $747,000 | -36.1% | 98,284 | -51.1% | 0.02% | -27.3% |
| Q2 2018 | $1,169,000 | -25.9% | 200,921 | -39.2% | 0.02% | -33.3% |
| Q1 2018 | $1,578,000 | +30.8% | 330,731 | +39.5% | 0.03% | +26.9% |
| Q4 2017 | $1,206,000 | +1877.0% | 237,000 | +1948.0% | 0.03% | +2500.0% |
| Q3 2017 | $61,000 | -90.8% | 11,572 | -90.2% | 0.00% | -92.3% |
| Q2 2017 | $660,000 | +500.0% | 118,674 | +1019.8% | 0.01% | +333.3% |
| Q4 2015 | $110,000 | -95.9% | 10,598 | -95.5% | 0.00% | -96.4% |
| Q3 2015 | $2,662,000 | +28.5% | 233,481 | +11.8% | 0.08% | +78.7% |
| Q3 2014 | $2,071,000 | -44.5% | 208,851 | -28.9% | 0.05% | -61.2% |
| Q2 2014 | $3,732,000 | – | 293,605 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |